Alnylam Pharmaceuticals (ALNY) Debt Ratio (2016 - 2022)

Alnylam Pharmaceuticals' Debt Ratio history runs 7 years deep, the most recent figure standing at 0.2 for Q2 2022.

• Quarterly Debt Ratio rose 64.87% year-over-year to 0.2 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was 0.2 (up 64.87% YoY) and the FY2021 annual result came in at 0.19, up 230.35% from the prior year.
• Debt Ratio was 0.2 for Q2 2022 at Alnylam Pharmaceuticals, up from 0.2 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.2 in Q2 2022 and bottomed at 0.01 in Q2 2019.
• A 5-year average of 0.08 and a median of 0.06 in 2020 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2018 — Debt Ratio slumped 88.21% — and 2022, when it surged 234.87%.
• Alnylam Pharmaceuticals' Debt Ratio stood at 0.02 in 2018, then slumped by 42.03% to 0.01 in 2019, then soared by 408.35% to 0.06 in 2020, then soared by 230.35% to 0.19 in 2021, then gained by 9.72% to 0.2 in 2022.
• Business Quant data shows ALNY's Debt Ratio at 0.2 in Q2 2022, 0.2 in Q1 2022, and 0.19 in Q4 2021.